Company

ARRAY BIOPHARMA INC (0001100412)

Standardized SEC financial data for ARRAY BIOPHARMA INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001100412 · Pharmaceutical Preparations.

Gross margin

65.8%

Operating margin

-74.8%

Net margin

-84.8%

Revenue growth (YoY)

15.2%

Return on equity

-67.0%

ROIC

-51.1%

Free cash flow

-$121.0M

Debt / equity

0.44×

Ratios for fiscal year 2018, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018
Revenue	$137.9M	$150.9M	$173.8M
Cost of revenue	$23.2M	$35.4M	$59.4M
Gross profit	$114.7M	$115.5M	$114.4M
R&D expense	$160.7M	$178.2M	$185.8M
SG&A expense	$36.3M	$39.3M

Balance sheet

USD	FY2016	FY2017	FY2018
Cash & equivalents	$56.6M	$235.1M	$413.4M
Inventory	—	—	$21.5M
Total current assets	$155.3M	$270.2M	$451.5M
Property, plant & equipment	$6.7M	$8.1M	$7.1M
Total assets	$168.9M	$279.1M

Cash flow

USD	FY2016	FY2017	FY2018
Operating cash flow	-$70.1M	-$39.4M	-$119.8M
Capital expenditures	$3.2M	$3.5M	$1.2M
Free cash flow	-$73.2M	-$42.9M	-$121.0M
Investing cash flow	$66.0M	-$58.1M	-$191.0M
Financing cash flow	$5.0M	$166.8M

Get 0001100412 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001100412/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001100412/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001100412 filings on SEC EDGAR →